The objective of this clinical trial is to assess the effectiveness of acetic acid in patients suffering from chronic cutaneous ulcers with biofilm. The primary question it seeks to address is whether acetic acid (as a 2% topical solution) is superior to the current standard treatment for chronic cutaneous ulcers with biofilm at our center (Prontosan®).
Participants will be randomly assigned to receive either the acetic acid solution treatment or the standard current treatment.

开始日期2024-09-01

申办/合作机构-

IRCT20240804062634N1 / Recruiting临床2期IIT

Investigating the effect of herbal shampoo containing Gharaghorot, vinegar and ajwain on head lice: a clinical trial study

开始日期2024-08-22

申办/合作机构-

NCT06525870 / Enrolling by invitation临床2期IIT

Efficacy of Topical 85%Trichloroacetic Acid in the Treatment of Low-grade Squamous Intraepithelial Lesion (LSIL) After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial

To determine the efficacy and HPV clearance of an application of 85% TCA compared to placebo in the treatment of LSIL. This is a randomized, single-blind, placebo-controlled study in 44 women aged 18-65 years with histologic-proved HPV/CIN1. The study will test whether 85% TCA application will be effective treatment in LSIL. The clinical study hypothesis is that TCA application at cervical lesion and transformation zone will achieve histologic complete remission of LSIL in significantly more patients than placebo therapy. Patients will be randomized to placebo (3% acetic acid) or 85%TCA topical application at cervical lesion and transformation zone. After 3 months, cytology, colposcopy, histology, and HPV testing will be performed. The primary endpoint is treatment efficacy defined as complete histologic remission at 3 months after treatment. The secondary endpoint is HPV clearance 3 months after treatment. The protocol for the project is approved by an Institutional Review Board (IRB). Project is totally supported by a grant from Rajavithi Hospital. There is no external funding.

开始日期2024-08-01

申办/合作机构

Rajavithi Hospital

100 项与酢酸相关的临床结果

登录后查看更多信息

100 项与酢酸相关的转化医学

登录后查看更多信息

100 项与酢酸相关的专利（医药）

登录后查看更多信息

2,366

项与酢酸相关的文献（医药）

2025-01-01·Biomaterials advances

Article

作者: Robinson, Thomas E. ; Schofield, Zoe ; Geoghegan, Joan A. ; Grover, Liam M. ; Moakes, Richard J A ; Robinson, Thomas E ; Clark, Callum ; Grover, Liam M ; Geoghegan, Joan A ; Moiemen, Naiem ; Moakes, Richard J.A.

Acetic acid is a promising alternative to antibiotics for topical applications, particularly burn wounds, however its site specificity and retention are impaired by poor material properties. In this study, acetic acid was investigated as both the gelling agent and antimicrobial active in alginate fluid gels. The formed microstructure was found to be directly dependent on acetic acid concentration, leading to highly tuneable material properties. At clinically relevant concentrations of 2.5-5 % acetic acid, the fluid gels were elastically dominated at rest, with viscosities up to 7 orders of magnitude greater than acetic acid alone. These material properties imparted long term surface retention and microparticle barrier function, not seen with either acetic acid or alginate solutions. Most notably, sprayability was enhanced simultaneously with the increased viscosity and elasticity due to the introduction of a discretised microstructure, leading to a remarkable tenfold increase in spray coverage. Formulation was found not to inhibit antimicrobial activity, despite the less acidic pH, with common burn wound pathogens Staphylococcus aureus and Pseudomonas aeruginosa being equally susceptible to the fluid gels as to acetic acid solutions.

2024-12-31·Gut microbes

B. thetaiotaomicron -derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma

Article

作者: Feng, Feiling ; Li, Yong ; Liang, Yingchao ; Yang, Liang ; Ma, Hongbin ; Hu, Jinxiang ; Liu, Fenghua ; Zhang, Rui ; Yuan, Lei

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, and emerging evidence suggests that the gut microbiota may play a role in its development and progression. In this study, the association between B. thetaiotaomicron, a gut microbiota species, and HCC recurrence, as well as patient clinical outcomes, was investigated. It was observed that B. thetaiotaomicron-derived acetic acid has the potential to modulate the polarization of pro-pro-inflammatory macrophagess, which promotes the function of cytotoxic CD8+ T cells. The increased biosynthesis of fatty acids was implicated in the modulation of pro-inflammatory macrophages polarization by B. thetaiotaomicron-derived acetic acid. Furthermore, B. thetaiotaomicron-derived acetic acid was found to facilitate the transcription of ACC1, a key enzyme involved in fatty acid biosynthesis, through histone acetylation modification in the ACC1 promoter region. Curcumin, an acetylation modification inhibitor, significantly blocked the inhibitory effects of B. thetaiotaomicron and acetic acid on HCC tumor growth. These findings highlight the potential role of gut microbiota-derived acetic acid in HCC recurrence and patient clinical outcomes, and suggest a complex interplay between gut microbiota, immune modulation, fatty acid metabolism, and epigenetic regulation in the context of HCC development. Further research in this area may provide insights into novel strategies for HCC prevention and treatment by targeting the gut microbiota and its metabolites.

2024-12-01·Synthetic and Systems Biotechnology

Article

作者: Zhao, Xin-Qing ; Xiong, Liang ; Qin, Jiufu ; Zhou, Ming-Hai ; Wang, Ya-Ting ; Takagi, Hiroshi

Acetic acid is a common inhibitor present in lignocellulose hydrolysate, which inhibits the ethanol production by yeast strains. Therefore, the cellulosic ethanol industry requires yeast strains that can tolerate acetic acid stress. Here we demonstrate that overexpressing a yeast native arginase-encoding gene, CAR1, renders Saccharomyces cerevisiae acetic acid tolerance. Specifically, ethanol yield increased by 27.3% in the CAR1-overexpressing strain compared to the control strain under 5.0 g/L acetic acid stress. The global intracellular amino acid level and compositions were further analyzed, and we found that CAR1 overexpression reduced the total amino acid content in response to acetic acid stress. Moreover, the CAR1 overexpressing strain showed increased ATP level and improved cell membrane integrity. Notably, we demonstrated that the effect of CAR1 overexpression was independent of the spermidine and proline metabolism, which indicates novel mechanisms for enhancing yeast stress tolerance. Our studies also suggest that CAR1 is a novel genetic element to be used in synthetic biology of yeast for efficient production of fuel ethanol.

项与酢酸相关的新闻（医药）

2024-08-28

·PRNewswire

The Chemical Peel Market is projected to grow by USD 814.4 million from 2024 to 2028, driven by rising demand for aesthetic treatments and technological advancements, AI-powered report- Technavio

NEW YORK, Aug. 28, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global chemical peel market size is estimated to grow by USD 814.4 millionn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 7.19% during the forecast period. Increasing demand for aesthetic procedures and technological advancement is driving market growth, with a trend towards increasing awareness about anti-aging measures. However, high cost of chemical peel products poses a challenge. Key market players include AbbVie Inc., AMOREPACIFIC Group Inc., Bausch Health Companies Inc., BeautyPharmaCo, Candela Corp., Caudalie International SE, Galderma SA, Hale Cosmeceuticals Inc, Image International Manufacturing LLC, Johnson and Johnson Services Inc., LOreal SA, MedPeel, Merz Pharma GmbH and Co KGaA, NEFTIS LABORATORIOS SL, Pierre Fabre SA, ProDerma Light, Radius Healthcare Pvt. Ltd., Renee Rouleau Inc., Topix Pharmaceuticals Inc., and Unilever PLC. Continue Reading Technavio has announced its latest market research report titled Global chemical peel market 2024-2028 Get a detailed analysis on regions, market segments, customer landscape, and companies - Click for the snapshot of this report Key Market Trends Fueling Growth The chemical peel market is experiencing significant growth due to the increasing awareness and demand for anti-aging procedures. In 2021 and 2022, there has been a rise in the number of cosmetic procedures performed in countries like the US, Brazil, Mexico, Germany, and Spain. This trend is driven by the advantages of chemical peels, including age spot reduction, sun damage removal, skin lightening, smoothening, and improved collagen growth. Vendors are actively promoting these benefits through various channels, such as websites, conferences, and magazine advertisements. Moreover, the increasing per capita income and economic development in emerging economies, particularly India and China, have led to a surge in online research and comparisons of various procedures. As a result, the chemical peel market is poised for continued growth during the forecast period. The Chemical Peel Market is witnessing significant growth due to the increasing demand for non-surgical skincare solutions. Trichloroacetic acid and Jessner's Solution are popular peeling agents used in chemical resurfacing for improving skin texture, reducing hyperpigmentation, acne scars, fine lines, and wrinkle reduction. These treatments are effective for sun damage, melasma treatment, and acne treatment. Medical aesthetics and cosmeceutical treatments using chemical formulations offer clinical benefits for various skin conditions. Glytone, Alpha hydroxy acid (AHA), sugar cane, sugar beets, lactic peel, milk, and Alpha-hydroxy acids (AHAs) are common peeling agents. Medium peels target the epidermis and dermis layers for enhanced skin health and beauty. The chemical peel procedure is a dermatologic treatment for skin health improvement and aesthetic enhancement. Discover a Comprehensive 360° Market Analysis: Understand the Impact of AI. For detailed information- Request Sample! Market Challenges The chemical peel market is currently facing a growth challenge due to the high cost of treatments, which is limiting its adoption, particularly in developing countries. The average price for a chemical peel ranges from USD600 to USD900, with significant variations depending on the type of peel. Light peels cost as low as USD150 but require multiple sessions for optimal results, while medium and deep peels can cost up to USD6,000. These high costs include fees for the chemical peel procedure, anesthesia, and operating room. The monopolistic approach of vendors, such as Allergan plc, in the market further contributes to the lack of competitive pricing. Allergan, a leading player in medical aesthetics, has acquired most of the market share, targeting high-income and upper-middle-class consumers. As a result, the inability of middle and lower-middle-class individuals to afford these costly procedures is hindering the growth of the global chemical peel market. The Chemical Peel market is thriving in the Skincare and Aesthetics industries, providing solutions for common concerns such as Acne, Pigmentation, and Wrinkle issues. Glytone's Peeling Solution, which contains Alpha Hydroxy Acids (AHAs) derived from Sugar Cane and Sugar Beets, is a popular choice for exfoliating the Epidermis. Medium Peels, using stronger Chemical Agents like TCA, reach deeper into the Dermis to address Acne spots, Dark Circles, and signs of Fatigue. Dermatology and Aesthetic Medicine professionals use these Dermatological Procedures for Skin Renewal, often combining different Chemical Compounds like Glycolic Acid, Lactic Acid, and Salicylic Acid for optimal results. The Beauty Industry continues to innovate with new Peeling Solutions, offering professional Chemical Exfoliation treatments for Facial Rejuvenation. For more insights on driver and challenges - Download a Sample Report Segment Overview This chemical peel market report extensively covers market segmentation by End-user 1.1 Hospital and recreation centers 1.2 Dermatology clinics Type 2.1 Light peel 2.2 Medium peel 2.3 Deep peel Geography 3.1 North America 3.2 Europe 3.3 APAC 3.4 South America 3.5 Middle East and Africa 1.1 Hospital and recreation centers- The Chemical Peel Market is experiencing steady growth due to increasing consumer awareness and demand for skin rejuvenation treatments. Businesses are offering various types of chemical peels to cater to diverse skin concerns, such as acne scars, aging, and sun damage. Market leaders are focusing on research and development to introduce innovative peel solutions and expand their customer base. Overall, the market is expected to continue its expansion in the coming years.For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 - 2022) - Download a Sample Report Research Analysis The Chemical Peel market encompasses a range of skincare treatments used in aesthetics to address various skin concerns, including acne, pigmentation, and wrinkle issues. These peels work by applying a chemical solution to the skin, causing it to exfoliate and peel off, revealing smoother, fresher skin. The solutions typically contain Alpha-hydroxy acids (AHAs) derived from fruits like glycolic acid from sugar cane and lactic peels from milk. Deeper peels may involve Phenol or Trichloroacetic acid, reaching the dermis for more significant results. Acne spots, dark circles, and signs of fatigue can also be targeted. Genetics and collagen production play a role in skin health, making chemical peels a popular choice for those seeking to improve their complexion in dermatology practices. Market Research Overview The Chemical Peel market encompasses a range of skincare treatments that utilize chemical solutions to improve the appearance of the skin. These peels are commonly used for various aesthetic concerns such as acne, pigmentation, and wrinkle issues. The solutions typically contain Alpha Hydroxy Acids (AHAs) derived from fruits like sugar cane and sugar beets, or Beta Hydroxy Acids (BHAs) like Salicylic Acid. The depth of the peel can vary from light to medium, affecting the epidermis or dermis layers. Chemical Peels are used to address acne spots, dark circles, fatigue, and signs of aging such as fine lines and wrinkles. The causes of these conditions can stem from genetics, sun damage, or lifestyle factors. The treatments promote collagen production, leading to skin renewal and texture improvement. Chemical Peels are considered a dermatological procedure and are also offered in aesthetic medicine clinics and the beauty industry. They provide a form of chemical exfoliation that goes beyond traditional cleansing methods. The solutions work by dissolving the bonds holding dead skin cells together, revealing smoother, healthier skin. Popular chemical peel formulations include Glytone, Jessner's Solution, TCA Peel, and various combinations of AHAs and BHAs. These treatments are administered as facial treatments in professional settings and are an essential part of medical aesthetics and cosmeceutical offerings. Chemical Peels contribute to skin health and beauty enhancement, addressing various skin conditions and concerns. They are an effective means of reducing hyperpigmentation, acne scars, sun damage, and melasma. The cosmetic procedure is a popular choice for individuals seeking wrinkle reduction and skin rejuvenation. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation End-user Hospital And Recreation Centers Dermatology Clinics Type Light Peel Medium Peel Deep Peel Geography North America Europe APAC South America Middle East And Africa 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

2024-07-26

·佰傲谷BioValley

【八月福州合成】黄建忠教授讲解“高附加值氨基酸及其衍生物的生物合成”！

黄建忠福建师范大学生命科学学院教授工业微生物发酵技术国家地方联合工程研究中心主任 NO.01 职务介绍教授（二级）、博导、留日博士。现为“工业微生物发酵技术国家地方联合工程研究中心”主任、“工业微生物教育部工程研究中心”主任、“海西绿色生物制造技术省部共建协同创新中心”主任、福建省生物化学与分子生物学会理事长。入选福建省“百千万人才工程”。曾任“中国生物化学与分子生物学会工业生化与分子生物学分会”副理事长（2013-2018）。 NO.02 研究方向与成果从事工业微生物代谢育种与调控研究。主持国家重大专项、国家“863”、国家自然科学基金、福建省重大专项等30多项课题的研究。获中国专利优秀奖1项，福建省科技进步二等奖2项、三等奖2项，福建省自然科学优秀论文一等奖1篇、中国科协优秀学术论文奖1篇。发表160多篇论文，授权发明专利48项，制定行业标准5项，建立了多个产学联合体。 NO.03 代表论文 *仅举例其中5篇（1）Hongxuan Wu，Jinhua Yang，Peijie Shen，Qingchen Li，Weibin Wu，Xianzhang Jiang，Lina Qin，Jianzhong Huang*，Xiao Cao，Feng Qi*. High-Level Production of Indole-3-acetic Acid in the Metabolically Engineered Escherichia coli. Journal of Agricultural and Food Chemistry，2021，DOI: 10.1021/acs.jafc.0c08141 （2）Quanxiu Gao，Hao Chen，Gaoyan Wang，Wei Yang，Xiaotong Zhong，Jiezheng Liu，XiaoJing Huo，Weifeng Liu， Jianzhong Huang*，Yong Tao*， Baixue Lin*. Highly Efficient Production of Menaquinone‑7 from Glucose by Metabolically Engineered Escherichia coli. ACS Synthetic Biology，2021，DOI：10.1021/acssynbio.0c00568 （3） Wenji n Jia，Huan Li，Qian Wang，Kaixuan Zheng，Hong Lin，Xin Li，Jianzhong Huang*，Linting Xu，Wanqian Dong，Zhengyu Shu*. Screening of perhydrolases to optimize glucose oxidase-perhydrolase-in situ chemical oxidation cascade reaction system and its application in melanin decolorization. Journal of Biotechnology，2021，DOI: 10.1016/j.jbiotec.2021.01.013 （4）Mingliang Zhang， Huaidong Zhang*， Qin Li， Yangle Gao， Lijun Guo，Liu He，Shanshan Zang，Xing Guo，Jianzhong Huang*，Li Li*. Structural Insights into the Trans-Acting Enoyl Reductase in the Biosynthesis of Long-Chain Polyunsaturated Fatty Acids in Shewanella piezotolerans. Journal of Agricultural and Food Chemistry，2021，DOI ：10.1021/acs.jafc.0c07386 （5） Xiaolei Guo， Weibin Wu，·Mingliang Zhang，Licheng Wu，Jianzhong Huang*. A bi-enzymatic cascade to yield pyruvate as co-substrate for L-tyrosine production. Applied Microbiology and Biotechnology，2020，DOI ：10.1007/s00253-020-10975-4 *点击图片，跳转会议推文 FUZHOU 2024第一届合成生物技术与智能生物制造学术交流会暨中国微生物学会生化过程模型化与控制专业委员会年会 *上下滑动，查看更多议程点击“阅读原文”，查看更多精彩内容~

2024-07-24

·米内网

【重磅】齐鲁拿下2亿大品种，今年第27个

精彩内容 7月24日，NMPA官网显示，齐鲁制药以仿制4类报产的醋酸加尼瑞克注射液获批上市，为国产第4家。醋酸加尼瑞克注射液为辅助生育药物，2023年在中国公立医疗机构终端销售额超过2亿元。醋酸加尼瑞克是一种促性腺激素释放激素(GnRH)的拮抗剂，可竞争性阻断垂体促性腺细胞上的GnRH受体，从而产生一种快速、可逆的促性腺激素分泌抑制作用。该产品在接受辅助生殖技术(ART)控制性卵巢刺激(COS)方案的妇女中使用，用于预防过早出现促黄体激素(LH)峰。米内网数据显示，2023年中国城市公立医院、县级公立医院、城市社区中心以及乡镇卫生院（简称中国公立医疗机构）终端醋酸加尼瑞克注射液销售额超过2亿元，同比增长20.78%。中国公立医疗机构终端醋酸加尼瑞克注射液销售情况（单位：万元）来源：米内网中国公立医疗机构药品终端竞争格局除了原研厂家默克，国内市场还有正大天晴、苏州二叶制药、翰宇药业的醋酸加尼瑞克注射液已获批上市，齐鲁制药为该产品国产第4家。今年以来，齐鲁制药已有27个品种获批上市，包括3款生物类似药、24款新注册分类仿制药。其中，注射用罗普司亭为国内首款生物类似药，艾曲泊帕乙醇胺片、盐酸苯达莫司汀注射用浓溶液、氯苯唑酸葡胺软胶囊、二甲双胍恩格列净片(Ⅵ)、恩曲利匹丙诺片等为国内首仿，彰显公司研发实力。资料来源：米内网数据库、NMPA注：米内网《中国公立医疗机构药品终端竞争格局》，统计范围是：中国城市公立医院、县级公立医院、城市社区中心以及乡镇卫生院，不含民营医院、私人诊所、村卫生室；上述销售额以产品在终端的平均零售价计算。本文为原创稿件，转载请注明来源和作者，否则将追究侵权责任。投稿及报料请发邮件到872470254@qq.com稿件要求详询米内微信首页菜单栏商务及内容合作可联系QQ：412539092 【分享、点赞、在看】点一点不失联哦

上市批准生物类似药

100 项与酢酸相关的药物交易

登录后查看更多信息

外链

KEGG	Wiki	ATC	Drug Bank
D00010	酢酸	S02AA10 G01AD02	DB03166

研发状态

10 条进展最快的记录,

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
避孕	临床2期	中国	上海新亚药业闵行有限公司	2024-06-03
避孕	临床2期	中国	上海市生物医药技术研究院	2024-06-03

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


EADV2023	N/A	斑秃	40	Trichloroacetic Acid 35%	夢夢糧壓齋餘築築願積(遞壓廠獵願顧襯願遞顧) = 鬱窪壓齋鏇餘鹹蓋壓製蓋艱醖顧鬱淵鬱鬱鹹網 (選鬱獵醖衊簾襯構範艱 )	积极	2023-10-11
TRICIN (ESGO2022)	临床2期	宫颈上皮内瘤样病变 HPV 16 \| other high risk types	102	85% TCA	夢憲製範糧憲鏇醖製蓋(膚鑰遞顧衊憲鑰窪齋構) = 夢鏇艱網膚餘衊廠範鬱獵壓淵鹽糧構構積糧網 (壓觸獵憲憲構膚膚艱鏇, 66.0 ~ 83.5) 更多	积极	2022-10-20
EADV2022	N/A	瘢痕	30	Trichloroacetic acid	構襯積範鬱鹹餘觸廠夢(廠蓋餘積構鹹憲積憲衊) = 築範製顧製襯構範鹽築鏇願鏇簾築觸範築簾築 (願簾膚鏇艱艱艱壓鏇選 )	-	2022-09-07
TECAIN (IAS2021)	N/A	肛门上皮内瘤变	155	topical trichloroacetic acid (Electrocautery)	網願簾鏇鹽鹽築醖鬱範(窪顧範鬱遞獵淵窪觸蓋) = 淵淵廠夢顧觸範壓構窪鬱糧鑰壓簾顧醖選齋餘 (齋鹹鬱築鏇艱淵鑰獵鹽 )	-	2021-01-01
TECAIN (IAS2021)	N/A	肛门上皮内瘤变	155	Topical trichloroacetic acid	網願簾鏇鹽鹽築醖鬱範(窪顧範鬱遞獵淵窪觸蓋) = 窪構網願夢糧憲繭憲窪鬱糧鑰壓簾顧醖選齋餘 (齋鹹鬱築鏇艱淵鑰獵鹽 )	-	2021-01-01
NCT02614703 (CTgov)	临床2/3期	巴雷特食管	60	Chromoendoscopy using Acetic Acid 2.5% (Chromoendoscopy Using Acetic Acid 2.5%)	夢遞選顧膚淵獵齋窪鑰(醖獵範鬱淵觸鏇積淵鬱) = 簾廠窪艱壓觸顧廠憲鹽齋網遞餘範廠憲觸窪繭 (醖網糧觸範鏇積製遞衊, 廠遞獵製願鑰壓鹽獵築 ~ 網襯構廠夢夢鏇範積觸) 更多	-	2019-08-26
NCT02614703 (CTgov)	临床2/3期	巴雷特食管	60	Standard random esophageal biopsies (Standard Random Esophageal Biopsies)	夢遞選顧膚淵獵齋窪鑰(醖獵範鬱淵觸鏇積淵鬱) = 廠鹽淵遞鏇鹽願鑰鑰範齋網遞餘範廠憲觸窪繭 (醖網糧觸範鏇積製遞衊, 鏇範鏇襯糧蓋窪膚襯膚 ~ 鹹鏇鏇壓製鹽鏇蓋夢遞) 更多	-	2019-08-26
ISN WCN2019	N/A	腹膜疾病	-	Acetic acid (2%)	餘鏇簾壓願鹽觸廠艱憲(範鏇壓繭夢觸鏇鑰窪選) = 獵餘夢網範構範淵鹽蓋鹹醖夢夢鏇願積遞繭壓 (醖積淵遞構製構範淵廠, 44.4)	-	2019-07-01
ISN WCN2019	N/A	腹膜疾病	-	Mupirocin	餘鏇簾壓願鹽觸廠艱憲(範鏇壓繭夢觸鏇鑰窪選) = 遞積壓鏇餘鑰網積獵夢鹹醖夢夢鏇願積遞繭壓 (醖積淵遞構製構範淵廠, 37.1)	-	2019-07-01